Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > I did some deep DD/ digging….what could Onc be worth?

<< Previous

Bullboard Posts

Next >>

Comment by westcoast1000on Aug 08, 2022 2:10pm

242 Views

Post# 34879409

RE:RE:RE:RE:RE:RE:RE:I did some deep DD/ digging….what could Onc be worth?

First tying up with mining and oil/gas speculators ended up being a headwind. The wind has now favorably turned and is coming from ONCY's back as the right course was set.

-We all hope that is true.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing